Dermal Toxicity Testing Market to Grow with a CAGR of 8.17% through 2031
Growing Ban on Animal Testing and Shift Toward Alternative Methods and Increased Investments in Research & Development (R&D) are expected to drive the Global Dermal Toxicity Testing Market growth in the forecast period, 2027-2031
According to TechSci Research's report, “Dermal Toxicity Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2031F,” the global dermal toxicity testing market is projected to grow from USD 2.11 billion in 2025 to USD 3.38 billion by 2031, at an 8.17% CAGR.
Governments and regulatory agencies worldwide have established stringent safety assessment protocols for pharmaceuticals, cosmetics, and industrial chemicals, mandating rigorous dermal toxicity testing to ensure consumer protection. Agencies such as the U.S. FDA, the European Medicines Agency (EMA), and the OECD require compliance with strict toxicity evaluation standards, thereby compelling companies to adopt advanced testing methodologies and driving market demand. The industry is undergoing a technological shift, with 3D cell culture models, organ-on-chip platforms, and AI-driven predictive analytics redefining toxicity assessment. These innovations offer greater accuracy, scalability, and efficiency, reducing reliance on animal testing while meeting regulatory benchmarks. Companies investing in next-generation toxicity screening are gaining a competitive edge by accelerating product validation and regulatory approvals.
The pharmaceutical industry is a major driver of dermal toxicity testing, particularly for topical formulations, transdermal drug delivery systems, and dermatological therapies. With rising cases of chronic skin disorders and the demand for targeted dermatological treatments, the need for robust, high-precision toxicity assessments continues to grow. Similarly, the chemical sector—including industrial, agricultural, and household chemicals—depends on comprehensive toxicity evaluations to comply with global safety regulations. Stricter enforcement of chemical safety laws, such as REACH (EU) and TSCA (U.S.), has increased reliance on alternative toxicity testing solutions, propelling market growth. Shifting consumer expectations toward clean, cruelty-free, and sustainably sourced beauty products is pushing cosmetic brands to eliminate animal testing and adopt ethical toxicity assessment methods. The surge in organic, vegan, and chemical-free skincare products has intensified the focus on safety validation without compromising ethical standards, further accelerating demand for advanced non-animal testing solutions. In this evolving landscape, companies that leverage cutting-edge dermal toxicity testing technologies are well positioned to navigate regulatory complexities, meet ethical consumer demands, and drive innovation in product safety.
Browse
over xx market data Figures spread through xx Pages and an in-depth TOC on
"Global Dermal Toxicity Testing Market”
Global
Dermal Toxicity Testing Market is segmented into Test Type, Testing Method Type,
End user, Regional Distribution and Company.
Based on Test Type, Global Dermal Toxicity Testing
market is divided into Skin Irritation Tests, Skin Sensitization Tests. The Skin
Irritation Tests segment accounted for the largest revenue share in 2022 and is
expected to exhibit a rapid CAGR over the forecast period. This can be attributed to the marked increase in awareness of the potential risks associated with substances applied to the skin. Also, strong demand for comprehensive dermal toxicity test services, ensuring
the safety of consumers and introducing new chemical entities and products will
further propel the growth of Global Dermal Toxicity Testing Market
during the forecast period. The growth of the dermal toxicity market is also fueled by advances in testing technologies, which have transformed dermal toxicity assessment.
Based on region, Asia Pacific is poised to witness fastest market growth in the Global Dermal Toxicity Testing Market. Asia-Pacific has emerged as a global hub for pharmaceutical R&D and chemical manufacturing, with major investments from multinational corporations and domestic players. India and China are dominant in API (Active Pharmaceutical Ingredient) production, and as drug development activities increase, demand for alternative dermal toxicity testing methods is rising. The chemical sector, particularly in China, Japan, and South Korea, is under stringent regulatory scrutiny, leading to a shift towards advanced toxicology assessments. Asia-Pacific consumers are increasingly favoring cruelty-free, organic, and dermatologically safe cosmetics, driving demand for alternative testing solutions. South Korea, known for its K-beauty industry, has been at the forefront of innovation in non-animal dermatological safety testing. Japanese and Australian markets are also witnessing a shift towards sustainable and ethical skincare, prompting companies to invest in in vitro and AI-driven toxicity testing technologies. Countries such as China, Japan, South Korea, and India are investing heavily in biotechnology research and advances in toxicology. Public-private partnerships and increased funding for biotech startups focusing on 3D human skin models, microfluidic devices, and AI-powered toxicity prediction models are accelerating market expansion
Major
companies operating in Global Dermal Toxicity Testing Market
are:
- SGS S.A.
- Covance, Inc
- Bio-Rad Laboratories Inc.
- Qiagen N.V.
- GE Healthcare
- Eurofins Scientific Inc
- Merck KgaA
- Thermo Fisher Scientific, Inc.
- Charles River Laboratories International, Inc.
- Catalent, Inc.
Download Free Sample Report
Customers can also request for 10% free
customization on this report.
“The North America region is expected to
witness significant growth of Global Dermal Toxicity Testing market owing to
the sophisticated healthcare infrastructure, supportive government regulations,
the increasing presence of prominent market players, advanced infrastructure
& shifting focus on drug discovery in the region. Technological
advancements and increasing adoption of in-vitro testing methods in the region
also act as drivers for the growth of in-vitro toxicology testing market. The
launch of biologics by biopharmaceutical companies in the United States has led to rapid adoption of toxicology testing. The expansion of laboratory
capabilities in the region has enabled clients to build toxicological profiles
of biopharmaceuticals, medical devices, chemicals, and cosmetics Brands that
prioritize responsible testing practices gain consumer trust and loyalty. As
public awareness of ethical considerations rises, companies are motivated to
adopt advanced, non-animal testing methods which is the major factor driving
the growth of the global Dermal Toxicity Testing Market during the forecast
period” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Dermal Toxicity Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type (Skin Irritation Tests, Skin Sensitization Tests), By Testing Method Type (In Vivo Testing (Animal-Based Tests) and In Vitro Testing (Cell-Based or Tissue-Based Tests)), By End User (Pharmaceuticals industries, Cosmetics and personal care products industry, Chemical Industry, Other), By Region & Competition, 2021-2031F",
has evaluated the future growth potential of Global Dermal Toxicity Testing Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Dermal Toxicity Testing Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com